Michelle Carnahan, a seasoned healthcare executive, has raised $52 million in seed money for her startup, Arbiter, which connects health care professionals and payers to improve patient care. The funding came from family offices like TriEdge Investments and gives Arbiter a $400 million valuation.

Carnahan left Eli Lilly after 26 years to join Thirty Madison, where she helped achieve a $1 billion valuation during the 2021 venture capital boom. Thirty Madison was later acquired by Remedy Meds in a $500 million all-stock deal.

Arbiter, only six months old, aims to unite payers, providers, and patients on an AI-powered platform to enhance patient care. The startup is already live with over 1,000 clinicians, with support from family offices and the acquisition of SecondWave Delivery Systems.

SecondWave Delivery Systems, founded by MFO Ventures co-founder Erick Moskow, aligns well with Arbiter’s mission to rebuild the healthcare system’s operating spine. Carnahan intends to make healthcare more proactive and less reactive through Arbiter.

Arbiter’s goal is to transform healthcare into a connected system that works for everyone, addressing the fragmentation in the industry. Board member Clive Fields emphasizes the importance of timely care and connection for patients in need.

Read more at Yahoo Finance: Seasoned Healthcare Executive Raises $52 Million For An AI Health Startup